Copyright
©The Author(s) 2024.
World J Gastrointest Endosc. Sep 16, 2024; 16(9): 509-518
Published online Sep 16, 2024. doi: 10.4253/wjge.v16.i9.509
Published online Sep 16, 2024. doi: 10.4253/wjge.v16.i9.509
Characteristics | Univariate analysis | Multivariate analysis | |||
Non-stricture (n = 20) | Stricture (n = 100) | P value | OR (95%CI) | P value | |
Age (year) | 66.70 ± 10.41 | 67.09 ± 7.09 | 0.84 | - | - |
Gender [n (%)] | 0.12 | ||||
Male | 11 (55.0) | 129 (70.5) | |||
Female | 9 (45.0) | 54 (29.5) | |||
BMI | 22.81 ± 3.72 | 22.82 ± 2.97 | 0.99 | - | - |
Smoke [n (%)] | 0.31 | ||||
Yes | 3 (15.0) | 25 (25.0) | - | - | |
No | 17 (85.0) | 75 (75.0) | - | - | |
Histopathologic diagnosis [n (%)] | 0.21 | ||||
High-grade intraepithelial neoplasia | 6 (30.0) | 45 (45.0) | - | - | |
Esophageal squamous cell carcinoma | 14 (70.0) | 55 (55.0) | - | - | |
Additional chemoradiotherapy [n (%)] | 0.54 | ||||
Yes | 2 (10.0) | 15 (15.0) | 2.12 (0.41-11.10) | 0.37 | |
No | 18 (90.0) | 85 (85.0) | Reference | - | |
Tumor location [n (%)] | 0.51 | ||||
Cervical and upper thoracic esophagus | 6 (30.0) | 20 (20.0) | Reference | ||
Middle thoracic esophagus | 10 (50.0) | 50 (50.0) | 1.77 (0.49-6.41) | 0.38 | |
Lower thoracic esophagus | 4 (20.0) | 30 (30.0) | 3.06 (0.64-14.53) | 0.16 | |
Macroscopic type [n (%)] | 0.89 | ||||
0-IIa | 4 (20.0) | 16 (16.0) | - | - | |
0-IIb | 11 (55.0) | 60 (60.0) | - | - | |
0-IIc | 5 (25.0) | 24 (24.0) | - | - | |
Clinical depth of invasion [n (%)] | 0.79 | ||||
Epithelium/lamina propria | 16 (80.0) | 73 (73.0) | - | - | |
MM/SM1 | 3 (15.0) | 19 (19.0) | - | - | |
SM2 | 1 (5.0) | 8 (8.0) | - | - | |
Procedure time (minute) | 105.00 ± 62.56 | 81.53 ± 5.46 | 0.08 | - | - |
Endo-knife [n (%)] | 0.17 | ||||
Hook knife | 2 (10.0) | 7 (7.0) | - | - | |
IT/Dual knife | 18 (90.0) | 84 (84.0) | - | - | |
Hybrid knife | 0 (0.0) | 9 (9.0) | - | - | |
Electrosurgical unit modes [n (%)] | 0.64 | ||||
Swift coagulation | 2 (10.0) | 10 (10.0) | - | - | |
Forced coagulation | 15 (75.0) | 82 (82.0) | - | - | |
Endocut | 3 (15.0) | 8 (8.0) | - | - | |
Submucosal injection solution [n (%)] | 0.04 | ||||
Sodium hyaluronate | 4 (20.0) | 5 (5.0) | 0.15 (0.03-0.82) | 0.03 | |
Other | 16 (80.0) | 95 (95.0) | Reference | ||
Steroids group [n (%)] | 0.93 | ||||
Oral steroids | 9 (45.0) | 44 (44.0) | Reference | ||
Combined group | 11 (55.0) | 56 (56.0) | 0.60 (0.20-1.82) | 0.37 | |
Longitudinal length of the resected lesion (mm) | 63.60 ± 21.77 | 60.37 ± 21.03 | 0.53 | - | - |
Circumferential range [n (%)] | 0.01 | ||||
< 5/6 and ≥ 3/4 | 17 (85.0) | 57 (57.0) | 0.19 (0.05-0.74) | 0.02 | |
≥ 5/6 | 3 (15.0) | 43 (43.0) | Reference | ||
En bloc resection [n (%)] | 0.91 | ||||
Yes | 17 (85.0) | 84 (84.0) | - | - | |
No | 3 (15.0) | 16 (16.0) | - | - | |
Fibrin glue [n (%)] | 0.12 | ||||
Yes | 9 (45.0) | 64 (64.0) | - | - | |
No | 11 (55.0) | 36 (36.0) | - | - |
- Citation: Wang QX, Ding Y, Qian QL, Zhu YN, Shi RH. Predictors of stricture after endoscopic submucosal dissection of the esophagus and steroids application. World J Gastrointest Endosc 2024; 16(9): 509-518
- URL: https://www.wjgnet.com/1948-5190/full/v16/i9/509.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i9.509